NCT04204603 - A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate | Biotech Hunter

Enrollment

122

Participants

Timeline

Start Date

November 30, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

October 29, 2019

Conditions

Rheumatoid Arthritis

Interventions

DRUG

CKD-506

Tablets for oral administration

DRUG

Placebo

Tablets for oral administration

Trial Locations (38)

Unknown

182RA18009 Stie# CZ06, Broumov

182RA18009 Stie# CZ03, Olomouc

182RA18009 Stie# CZ02, Prague

182RA18009 Stie# CZ05, Prague

182RA18009 Stie# CZ07, Prague

182RA18009 Stie# CZ08, Prague

182RA18009 Stie# CZ09, Prague

182RA18009 Stie# CZ01, Uherské Hradiště

182RA18009 Stie# UA03, Lviv

182RA18009 Stie# GE01, Tbilisi

182RA18009 Stie# GE02, Tbilisi

182RA18009 Stie# GE03, Tbilisi

182RA18009 Stie# PL04, Bydgoszcz

182RA18009 Site# PL01, Elblag

182RA18009 Stie# PL03, Grodzisk Mazowiecki

182RA18009 Stie# PL02, Katowice

182RA18009 Stie# PL07, Lodz

182RA18009 Stie# PL06, Poznan

182RA18009 Stie# PL08, Poznan

182RA18009 Stie# PL05, Skierniewice

182RA18009 Stie# PL10, Torun

182RA18009 Stie# PL09, Warsaw

182RA18009 Stie# RF05, Moscow

182RA18009 Stie# RF10, Moscow

182RA18009 Stie# RF09, Perm

182RA18009 Stie# RF03, Saint Petersburg

182RA18009 Stie# RF08, Saint Petersburg

182RA18009 Stie# RF02, Tolyatti

182RA18009 Stie# RF07, Tver'

182RA18009 Stie# RF06, Vladimir

182RA18009 Stie# UA10, Ivano-Frankivsk

182RA18009 Stie# UA09, Kharkiv

182RA18009 Stie# UA01, Kyiv

182RA18009 Stie# UA04, Kyiv

182RA18009 Stie# UA07, Kyiv

182RA18009 Stie# UA11, Kyiv

182RA18009 Stie# UA05, Vinnytsia

182RA18009 Stie# UA06, Vinnytsia